Cited by 11Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsAtrial Fibrillation Management and Outcomes

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis

Open access
Khan, Faizan, Rahman, Alvi, Carrier, Marc, Kearon, Clive, Schulman, Sam, Couturaud, Francis, Prandoni, Paolo, Eichinger, Sabine +10 more·2017·BMJ Open

Abstract

Introduction: For patients with a first unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulation is a crucial clinical dilemma which has yet to be resolved. The decision to stop anticoagulant therapy (AT) after the initial 3–6 months or to continue AT indefinitely, is primarily governed by the long-term risk of recurrence when treatment is discontinued. This risk however, is not well established, hindering decision making. Methods and analysis: We will conduct a systematic review and a meta-analysis of studies involving patients diagnosed with a first, symptomatic unprovoked VTE or VTE provoked by minor transient risk factors, who have completed at least 3 months of initial AT; and who were followed-up for standardised time intervals of 1, 2, 5, 10 and 20 years (±3 months) after stopping AT. We will search (from inception to January 2017) MEDLINE, Embase and the Cochrane library for randomised controlled trials and prospective observational studies. Two reviewers will conduct all screening and data collection independently. The primary outcome of the rate of recurrent VTE at the standardised time intervals will be calculated for each study from the total number of recurrent events and the corresponding number of patient-years of follow-up. We will use a random-effects model to pool study results and report a weighted estimate of the absolute rate of recurrent VTE (events per 100 patient-years) over standardised time intervals of 1, 2, 5, 10 and 20 years after discontinuing anticoagulants. Ethics and dissemination: Ethical approval is not applicable for this study. Findings from this study will be disseminated through peer-reviewed journal publication as well as relevant national and international conference presentations. PROSPERO registration number: CRD42017056309.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2017-016950

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Khan, F., Rahman, A., Carrier, M., Kearon, C., Schulman, S., Couturaud, F., Prandoni, P., Eichinger, S., Becattini, C., Agnelli, G., Büller, H. R., Brighton, T. A., Palareti, G., Pinede, L., Sabri, E., Hutton, B., Wells, G. A., & Rodger, M. A.
Affiliations
  • University of Ottawa (CA)
  • McMaster University (CA)
  • Departmentof Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
  • University of Padua (IT)
  • Medical University of Vienna (AT)
  • University of Perugia (IT)
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
  • Prince of Wales Hospital (AU)
  • University of Bologna (IT)
  • Department of Internal Medicine, Infirmerie Protestante, Lyon, France
  • Ottawa Hospital Research Institute (CA)
Corresponding author
Khan, Faizan
Venue
BMJ Open
Publisher
BMJ
Published
2017-09
Volume
7
Issue
9
Pages
016950
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2759233833
Cited by
11
References
37
Citations by year
2024: 2 · 2022: 3 · 2021: 2 · 2019: 3 · 2016: 1
FWCI
0.21
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (acceptedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc)
Funders
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Bayer HealthCare
  • Daiichi-Sankyo
  • Novo Nordisk
  • LEO Pharma
  • Canadian Institutes of Health Research
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Keywords
unprovoked venous thromboembolism, anticoagulation duration, anticoagulation discontinuation, recurrent venous thromboembolism
MeSH terms
Systematic Reviews as Topic, Anticoagulants, Drug Administration Schedule, Humans, Recurrence, Research Design, Risk Factors, Meta-Analysis as Topic, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review